Report Detail

Pharma & Healthcare Global Cefprozil Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4712287
  • |
  • 29 June, 2026
  • |
  • Global
  • |
  • 124 Pages
  • |
  • GIR
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Cefprozil market size was valued at US$ 153 million in 2025 and is forecast to a readjusted size of US$ 190 million by 2032 with a CAGR of 3.2% during review period.
Cefprozil is a semi-synthetic broad-spectrum cephalosporin antibiotic, and it is a second-generation cephalosporin type antibiotic. It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections. It comes as a tablet and as a liquid suspension.
Global Cefprozil key players include Orchid, Taj Pharma, Dhanuka, Qilu Antibiotics, Dongying Pharma, etc. Global top five manufacturers hold a share over 45%.
India is the largest market, with a share about 50%, followed by China, and Europe, both have a share about 40 percent.
In terms of product, Anhydrous is the largest segment, with a share over 60%. And in terms of application, the largest application is Uncomplicated Skin, followed by Pharyngitis or tonsillitis, Secondary Bacterial Infection, Acute Sinusitis, etc.
This report is a detailed and comprehensive analysis for global Cefprozil market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cefprozil market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (USD/Kg), 2021-2032
Global Cefprozil market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (USD/Kg), 2021-2032
Global Cefprozil market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (USD/Kg), 2021-2032
Global Cefprozil market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (USD/Kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cefprozil
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cefprozil market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Orchid, Taj Pharma, Dhanuka, Lupin, Alkem, Corden Pharma, Aurobindo, Covalent, TEVA GROUP, Hetero Drugs, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cefprozil market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Anhydrous
Monohydrate
Market segment by Application
Pharyngitis or tonsillitis
Otitis Media
Acute Sinusitis
Secondary Bacterial Infection
Uncomplicated Skin
Other
Major players covered
Orchid
Taj Pharma
Dhanuka
Lupin
Alkem
Corden Pharma
Aurobindo
Covalent
TEVA GROUP
Hetero Drugs
Qilu Antibiotics
Dongying Pharma
Union Chempharma
Huafangpharm
Topfond
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cefprozil product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cefprozil, with price, sales quantity, revenue, and global market share of Cefprozil from 2021 to 2026.
Chapter 3, the Cefprozil competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cefprozil breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Cefprozil market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cefprozil.
Chapter 14 and 15, to describe Cefprozil sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Cefprozil Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Anhydrous
    • 1.3.3 Monohydrate
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Cefprozil Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Pharyngitis or tonsillitis
    • 1.4.3 Otitis Media
    • 1.4.4 Acute Sinusitis
    • 1.4.5 Secondary Bacterial Infection
    • 1.4.6 Uncomplicated Skin
    • 1.4.7 Other
  • 1.5 Global Cefprozil Market Size & Forecast
    • 1.5.1 Global Cefprozil Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Cefprozil Sales Quantity (2021-2032)
    • 1.5.3 Global Cefprozil Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Orchid
    • 2.1.1 Orchid Details
    • 2.1.2 Orchid Major Business
    • 2.1.3 Orchid Cefprozil Product and Services
    • 2.1.4 Orchid Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Orchid Recent Developments/Updates
  • 2.2 Taj Pharma
    • 2.2.1 Taj Pharma Details
    • 2.2.2 Taj Pharma Major Business
    • 2.2.3 Taj Pharma Cefprozil Product and Services
    • 2.2.4 Taj Pharma Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Taj Pharma Recent Developments/Updates
  • 2.3 Dhanuka
    • 2.3.1 Dhanuka Details
    • 2.3.2 Dhanuka Major Business
    • 2.3.3 Dhanuka Cefprozil Product and Services
    • 2.3.4 Dhanuka Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Dhanuka Recent Developments/Updates
  • 2.4 Lupin
    • 2.4.1 Lupin Details
    • 2.4.2 Lupin Major Business
    • 2.4.3 Lupin Cefprozil Product and Services
    • 2.4.4 Lupin Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Lupin Recent Developments/Updates
  • 2.5 Alkem
    • 2.5.1 Alkem Details
    • 2.5.2 Alkem Major Business
    • 2.5.3 Alkem Cefprozil Product and Services
    • 2.5.4 Alkem Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Alkem Recent Developments/Updates
  • 2.6 Corden Pharma
    • 2.6.1 Corden Pharma Details
    • 2.6.2 Corden Pharma Major Business
    • 2.6.3 Corden Pharma Cefprozil Product and Services
    • 2.6.4 Corden Pharma Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Corden Pharma Recent Developments/Updates
  • 2.7 Aurobindo
    • 2.7.1 Aurobindo Details
    • 2.7.2 Aurobindo Major Business
    • 2.7.3 Aurobindo Cefprozil Product and Services
    • 2.7.4 Aurobindo Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Aurobindo Recent Developments/Updates
  • 2.8 Covalent
    • 2.8.1 Covalent Details
    • 2.8.2 Covalent Major Business
    • 2.8.3 Covalent Cefprozil Product and Services
    • 2.8.4 Covalent Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Covalent Recent Developments/Updates
  • 2.9 TEVA GROUP
    • 2.9.1 TEVA GROUP Details
    • 2.9.2 TEVA GROUP Major Business
    • 2.9.3 TEVA GROUP Cefprozil Product and Services
    • 2.9.4 TEVA GROUP Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 TEVA GROUP Recent Developments/Updates
  • 2.10 Hetero Drugs
    • 2.10.1 Hetero Drugs Details
    • 2.10.2 Hetero Drugs Major Business
    • 2.10.3 Hetero Drugs Cefprozil Product and Services
    • 2.10.4 Hetero Drugs Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Hetero Drugs Recent Developments/Updates
  • 2.11 Qilu Antibiotics
    • 2.11.1 Qilu Antibiotics Details
    • 2.11.2 Qilu Antibiotics Major Business
    • 2.11.3 Qilu Antibiotics Cefprozil Product and Services
    • 2.11.4 Qilu Antibiotics Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Qilu Antibiotics Recent Developments/Updates
  • 2.12 Dongying Pharma
    • 2.12.1 Dongying Pharma Details
    • 2.12.2 Dongying Pharma Major Business
    • 2.12.3 Dongying Pharma Cefprozil Product and Services
    • 2.12.4 Dongying Pharma Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Dongying Pharma Recent Developments/Updates
  • 2.13 Union Chempharma
    • 2.13.1 Union Chempharma Details
    • 2.13.2 Union Chempharma Major Business
    • 2.13.3 Union Chempharma Cefprozil Product and Services
    • 2.13.4 Union Chempharma Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Union Chempharma Recent Developments/Updates
  • 2.14 Huafangpharm
    • 2.14.1 Huafangpharm Details
    • 2.14.2 Huafangpharm Major Business
    • 2.14.3 Huafangpharm Cefprozil Product and Services
    • 2.14.4 Huafangpharm Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Huafangpharm Recent Developments/Updates
  • 2.15 Topfond
    • 2.15.1 Topfond Details
    • 2.15.2 Topfond Major Business
    • 2.15.3 Topfond Cefprozil Product and Services
    • 2.15.4 Topfond Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Topfond Recent Developments/Updates

3 Competitive Environment: Cefprozil by Manufacturer

  • 3.1 Global Cefprozil Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Cefprozil Revenue by Manufacturer (2021-2026)
  • 3.3 Global Cefprozil Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Cefprozil by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Cefprozil Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Cefprozil Manufacturer Market Share in 2025
  • 3.5 Cefprozil Market: Overall Company Footprint Analysis
    • 3.5.1 Cefprozil Market: Region Footprint
    • 3.5.2 Cefprozil Market: Company Product Type Footprint
    • 3.5.3 Cefprozil Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Cefprozil Market Size by Region
    • 4.1.1 Global Cefprozil Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Cefprozil Consumption Value by Region (2021-2032)
    • 4.1.3 Global Cefprozil Average Price by Region (2021-2032)
  • 4.2 North America Cefprozil Consumption Value (2021-2032)
  • 4.3 Europe Cefprozil Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Cefprozil Consumption Value (2021-2032)
  • 4.5 South America Cefprozil Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Cefprozil Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Cefprozil Sales Quantity by Type (2021-2032)
  • 5.2 Global Cefprozil Consumption Value by Type (2021-2032)
  • 5.3 Global Cefprozil Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Cefprozil Sales Quantity by Application (2021-2032)
  • 6.2 Global Cefprozil Consumption Value by Application (2021-2032)
  • 6.3 Global Cefprozil Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Cefprozil Sales Quantity by Type (2021-2032)
  • 7.2 North America Cefprozil Sales Quantity by Application (2021-2032)
  • 7.3 North America Cefprozil Market Size by Country
    • 7.3.1 North America Cefprozil Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Cefprozil Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Cefprozil Sales Quantity by Type (2021-2032)
  • 8.2 Europe Cefprozil Sales Quantity by Application (2021-2032)
  • 8.3 Europe Cefprozil Market Size by Country
    • 8.3.1 Europe Cefprozil Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Cefprozil Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Cefprozil Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Cefprozil Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Cefprozil Market Size by Region
    • 9.3.1 Asia-Pacific Cefprozil Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Cefprozil Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Cefprozil Sales Quantity by Type (2021-2032)
  • 10.2 South America Cefprozil Sales Quantity by Application (2021-2032)
  • 10.3 South America Cefprozil Market Size by Country
    • 10.3.1 South America Cefprozil Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Cefprozil Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Cefprozil Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Cefprozil Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Cefprozil Market Size by Country
    • 11.3.1 Middle East & Africa Cefprozil Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Cefprozil Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Cefprozil Market Drivers
  • 12.2 Cefprozil Market Restraints
  • 12.3 Cefprozil Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Cefprozil and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Cefprozil
  • 13.3 Cefprozil Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Cefprozil Typical Distributors
  • 14.3 Cefprozil Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Cefprozil. Industry analysis & Market Report on Cefprozil is a syndicated market report, published as Global Cefprozil Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Cefprozil market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report